Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial) - Dasgupta, A; Steinhubl, SR; Bhatt, DL (Am J Cardiol, 2009)
et al.